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Protein malnutrition up-regulates growth hormone receptor
expression in rat splenic B lymphocytes
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The reciprocal interaction between the endocrine and immune systems has been the subject of
active research during the last decade, and an important body of evidence has accumulated
supporting the role of the GH/IGF axis in immune function. More recently, the GH/IGF axis has
been postulated as playing an important role in the modulation of stress conditions, such as
catabolic stages, aging-related disorders, immunodeficient aids patients and malnutrition.
Whether these effects are exerted through endocrine, autocrine or paracrine mechanisms
remains to be determined for different immune cell types and tissues. The aim of the current
study was to define which specific subsets of lymphocytes are the primary targets for GH action.
In addition, the regulatory role of stress induced by protein restriction was investigated with
respect to the relative distribution of GH receptor positive lymphoid cells. Normal growing rats
were fed isocaloric diets with variable protein content (0, 4, 8, 12 and 20%) for a period of 14
days. The lymphoid cells were then separated from spleen, lymph nodes and peripheral blood
lymphocytes. Flow cytometry analysis measured the binding characteristics of Fluos-rrGH to
lymphocytes together with specific PE-labelled mAbs defining CD4+ and CD8+ T cells and B
lymphocytes. The pattern of expression of the GH receptor differed among the lymphoid tissues
and cell subsets. Spleen was the most responsive organ to protein deprivation with highest
GH receptor expression in B lymphocytes, followed by CD4+ T cells. As the protein intake was
decreased from 20% to 0%, the percentage of GHR positive cells increased from 12% to 52%
in splenic B lymphocytes and from 8% to 17% in CD4+ T cells. In contrast, only 10%-13% of
lymphocytes in lymph nodes and 2%-4% in circulation, showed binding sites to GH associated
with protein deprivation. In conclusion, the increase in GH receptors on lymphocytes under
catabolic stress induced by protein malnutrition gives support to the hypothesis of a modulatory
role of the GH/IGF axis in preserving the homeostasis of immune tissues.
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La desnutrición proteica estimula la expresión de receptores de la hormona del crecimiento
en linfocitos B esplénicos de rata
La interacción recíproca entre los sistemas endocrino e immune ha sido objeto en la última
década de numerosas investigaciones que han aportado evidencia sustancial sobre el papel
del eje GH/IGF-I en el sistema inmune. Recientemente, se ha postulado que el eje GH/IGF-I
ejerce una función importante en la modulación de condiciones de estrés, tales como estados
catabólicos, trastornos asociados con el envejecimiento, síndrome de inmunodeficiencia
adquirida y desnutrición. No se conoce aún si estos efectos son ejercidos a través de
mecanismos endocrinos, autocrinos o paracrinos en los diferentes tipos de tejidos del sistema
inmune. El objetivo de este estudio fue establecer los principales subtipos celulares linfoides
que son blanco de la acción de la hormona de crecimiento. Además, se estudió el efecto
regulador del estrés inducido por la desnutrición proteica sobre la distribución relativa de
células linfoides positivas al receptor de GH (GHR). Ratas normales se sometieron a dietas
isocalóricas de contenido variable de proteína (0, 4, 8, 12 y 20%) durante 14 días y se aislaron
los linfocitos de bazo, ganglios linfáticos y sangre periférica. Mediante citometría de flujo se
analizó la unión a Fluos-rrGH y los linfocitos CD4+, CD8+ y B se definieron empleando
anticuerpos monoclonales específicos marcados con PE. Se encontró que el patrón de
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expresión de GHR varía con el tejido y tipo celular linfoide. El bazo es el órgano más sensible
al déficit de proteína, y la mayor expresión de receptores para GH se presenta en las células B
seguidas por las células CD4+. Al reducir el contenido de proteína en la dieta de 20% a 0% se
observó un incremento del 12% al 52% en el número de células B positivas para el receptor de
GH y del 8% al 17% en las células CD4+ positivas para GHR en el bazo. En contraste, sólo el
10%-13% de linfocitos de los ganglios linfáticos y 2%-4% de la sangre periférica presentaron
receptores para GH en su superficie, los cuales no se vieron afectados significativamente por
el déficit de proteína. En conclusión, el incremento en los receptores para GH en linfocitos bajo
estrés catabólico inducido por la restricción en proteína, apoya la hipótesis del papel modulador
del eje GH/IGF-I en la preservación de la homeostasis del sistema inmune.
Palabras clave: receptor de hormona de crecimiento, malnutrición, linfocitos.
In recent years, it has become apparent that a
tight communication exists between the endocrine
and immune systems. Of particular importance
is the role of growth hormone (GH)/insulin-like
growth factor-I (IGF-I) axis in immune function.
GH and IGF-I contribute to regulate, in concert
with cytokines, the development and function of
the immune system. Whether these effects are
brought about through endocrine, autocrine or
paracrine mechanisms remains to be conclusively
determined for different immune cell types and
tissues (1,2).
Weigent et al. (3) first established the extra-
pituitary production of GH in human lymphocytes.
These researchers used fluorescent-labeled anti-
GH antibodies to show that the number of GH-
positive cells doubled in response to mitogenic
stimulation. This result was extended to show that
GH messenger RNA (mRNA) is expressed in
human lymphocytes and translated into a GH-
immunoreactive protein with a molecular weight
similar to that of pituitary GH (4). GH receptors
have been detected in normal lymphoid cells, as
well as in the transformed human lymphoblastoid
cell line IM-9 (5,6). In the rat the GH receptor (GHR)
has been shown to be widely expressed with
comparatively much lower levels of expression in
lymphoid tissues (7).
Nutrition is an important determinant of immune
responses; deficits in protein and calories have
deleterious effects on the host´s defense systems.
Both protein and energy intake are critical in the
regulation of serum levels of IGF-I, IGF binding
protein-3 (IGFBP-3), IGF binding protein-1
(IGFBP-1), GH and GH binding protein (GHBP),
as well as the expression levels of the GHR and
the IGF-I receptor (IGF-IR) (8-10). It is known that
a GH resistant state is induced during nutritional
stress, depending on the specific type and length
of nutrient deprivation (11). In humans and in
several other species, when food intake is
reduced, serum GH levels are increased (except
in the rat) and circulating levels of IGF-I, IGFBP-
3 and GH-BP are reduced (11,13).
Despite the growing knowledge of the actions of
GH on cells of the immune system, further studies
are needed to understand which specific subsets
of lymphocytes are the primary targets for GH
action (2). One approach to this question is the
quantitative analysis of the GH receptors on
subpopulations of lymphocytes using flow
cytometry.
The aim of this work was to study the binding
characteristics of recombinant rat GH (rrGH),
coupled to Fluos [5(6)-carboxyfluorescein-N-
hydrosuccinimide ester], to lymphocytes and to
determine the relative distribution of growth
hormone receptors on the cell subpopulations from
some lymphoid tissues in normal growing rats
under catabolic stress caused by protein
restriction. In addition some elements associated
to the GH/IGF-I axis were also determined.
Materials and methods
Animals and dietary protocol
Male Wistar rats (Instituto Nacional de Salud,
Bogotá, Colombia) weighing approximately 110 g
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were individually housed in steel metabolism cages
and were given a diet containing 12%  protein (i.e.,
12 g of crude protein per 100 g of food, ICN
Biomedicals, Aurora, OH) for a 5-day pre-
adaptation period. After this period, animals were
randomly assigned into five groups of six animals
each with diets including 0, 4, 8, 12 or 20% protein
for a period of 14 days (ICN Biomedicals, Aurora
OH). These five diets are isocaloric and each
provides 3.7 kcal/g. Rats were subjected to a light-
dark cycle of 12/12 h at a constant temperature of
22±2°C. Animals were given their diets in a
powdered form and had free access to tap water.
Individual food rations for the whole experimental
period were weighed. At the end of the experiment
the non-consumed food was weighed and feed
consumption calculated. Body weight was
measured every third day.
Sampling of blood and tissues
On day 0 blood samples were taken from the orbital
plexus under diethyl ether anesthesia and serum
samples were stored at -20°C. At the end of the
experiment rats were anaesthetized intra-
peritoneally with 0.4 ml/100 g body weight of
RompunTM (20 mg/ml)-KetalarTM (50 mg/ml)-saline
(9 g NaCl/l) (1:2:3 v/v) and exsanguinated by
cardiac puncture. A sample volume of 1 ml was
allowed to clot, the serum was separated and
frozen at -20°C until analysis, and 0.5 ml were
collected in heparinized tubes and processed for
determinations on PBL (peripheral blood
lymphocytes) by flow cytometry. Spleen and
mesenteric lymph nodes were removed quickly,
rinsed and placed in cold Hank's balanced salt
solution until processed by flow cytometry on the
same day. The animal protocol was approved by
the Animal Care and Use Committee of the National
University of Colombia (Bogotá, Colombia).
Flow cytometric analysis
Flow cytometric analysis was used to determine
the percentage of cells that were reactive for GHR
(GHR+) in rats fed various diets. Single cell
suspensions of splenocytes and from lymph nodes
were prepared in Hank's balanced salt solution.
The cells were washed and red blood cells in
splenocyte suspensions were lysed using PharM
LyseTM lysis solution (BD Pharmingen San Diego,
CA). Cells were resuspended in PBS (phosphate
buffer saline) containing 0.3% BSA and 0.1%
sodium azide. Cell viability was determined by
trypan blue exclusion using a hemocytometer.
The following monoclonal antibodies (mAb) were
purchased from BD Pharmingen: PE-conjugated
mouse anti-rat CD4, CD8, CD45RA and
immunoglobulin G1(IgG1) isotype control. The CD4
mAb was used to identify helper T-cells, the CD8
mAb was used to identify suppressor/cytotoxic T
cells, and the CD45RA mAb was used to identify
B cells.
Fluorescein labeling
Recombinant rat GH (rrGH) was obtained from the
National Hormone and Peptide Program, NIDDK
(Torrance, CA). Recombinant rGH was conjugated
to Fluos [5(6)-carboxyfluorescein-N-hydro-
succinimide ester] using a fluorescein labeling kit
(Boehringer Mannheim). Briefly, 1 mg of hormone
was dissolved in 1 ml of 100 mM sodium
bicarbonate buffer at a pH of 8.5. Fluos was
dissolved in dimethylsulfoxide at 20 mg/ml, and
10 µl of this solution was added to the dissolved
hormone. The resulting solution was gently stirred
for 2 h at room temperature in the dark. Free Fluos
was removed by gel filtration with Sephadex G-25
(Pharmacia) in PBS with 0.1% sodium azide. The
molar ratio of Fluos:protein (F/P) was
approximately 10:1. This ratio results in the
incorporation of approximately 3 to 5 molecules
of Fluos per molecule of rhGH. BSA-Fluos was
used as a control with similar F/P molar ratio. The
hormone-Fluos conjugate was mixed 1:1 with
glycerol and stored at -20 °C.
The first set of experiments was conducted to
investigate whether Fluos-rrGH was able to bind
to rat lymphocytes. The human IM-9 lympho-
blastoid cell line obtained from ATCC (American
Type Culture Collection) was used as a control.
For  time course and saturation studies, IM-9 cells
or splenocytes (1 x 106) were incubated with
increasing concentrations of fluos-rrGH (0.5 µg -
20 µg) at different times (0.5 h - 4 h) and processed
as indicated below for cytofluorometry. The binding
specificity was performed on both, IM-9 cells and
splenocytes; briefly, 1 x 106 cells were incubated
for 1 h with 1 µg of fluos-rrGH in the presence of
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30 µg or 100 µg of unlabeled rrGH and processed
as described previously (10). Fluos-BSA and FITC-
anti-mouse IgM were used as controls.
Cells derived from the corresponding tissues
mentioned above  (1 x 106 cells) and blood (50 µl)
were co-labeled in a set of three tubes with Fluos-
rrGH and either PE-anti CD4, PE-anti CD8, PE-
anti CD45RA in PBS containing 0.3% BSA and
0.1% sodium azide. Fluos-BSA and PE-IgG1 were
added to a different tube as control. Recombinant
rGH and BSA were used at a concentration of 1
µg/tube. Cells were then washed twice and
resuspended in PBS containing 1% paraformal-
dehyde. Red blood cells from the PBL samples
were lysed immediately after labeling using PharM
LyseTM lysis solution (BD Pharmingen, San Diego
CA) washed and resuspended as indicated above.
Cell acquisition was performed in a FACScanTM
flow cytometer, and a minimum of 50,000 events
was acquired for each test. Data were analyzed
using Cell-QuestTM software (Becton Dickinson).
Hormone determinations
Serum IGF-I, prolactin and GH levels were
measured by radioimmunoassay (RIA) (rat/mouse
IGF-I assay system, rat prolactin assay system
and rat GH system, National Hormone and
Pituitary Program. Harbor-UCLA medical Center,
Torrance, CA.  Kindly provided by Dr. A. F. Parlow).
Serum insulin levels were determined using a
highly sensitive rat insulin RIA kit (Linco Research
Inc., St.Charles, MO).
SDS-PAGE and Western ligand binding assay
Serum IGFBP levels were measured in serum
collected on day 15. Samples containing 2 µl of
serum were mixed with 2 µl of 2X nonreducing
SDS protein gel loading solution (Quality Biological
Inc. Gaithersburg, MD). The resulting samples were
then subjected to SDS-PAGE on 4-20% gradient
gels (Novex, San Diego, CA). Proteins were then
transferred to nitrocellulose membranes (0.2 µm)
using standard electroblotting methods.
Membranes were blocked with TBS (Tris Buffer
Saline) containing 1% BSA and incubated with
1.5 x 106 cpm of [125I]-IGF-I (Amersham, Chicago,
IL) overnight at 4°C in TBS with 0.1% tween-20.
Membranes were washed three times with TBS
containing 0.1% tween-20 and exposed to
Phosphorimager screens (Fuji Photo Film Co.,
Ltd., Kanagawa, Japan). Levels of IGFBP-3 and
IGFBP-1 were determined by quantifying the levels
of [125I]-IGF-I incorporated into bands
corresponding to 40-45 kd and 25-28 kd,
respectively.
Statistics
Statistical analyses were performed using the two-
tailed t test (SAS Institute Inc., 1999). Protein level
was considered the main source of variation and
mean comparisons for each variable under study
were performed between groups receiving different
protein diets. Values were considered to be
statistically different when P values were less than
0.05.
Results
Food consumption and body weight
Animals fed 0% and 4% protein diets each lost
40±5.1 g and 8.7±1.6 g of body weight,
respectively. At 8%, 12% and 20% protein diets,
rats gained 56.3±9.6 g, 64±9.6 g and 75±11.8 g
of body weight, respectively. Cumulative food
intake in grams over the 14-day period was as
follows: animals fed 20% protein diet, 259±5 g;
12%, 244±4 g; 8%, 240±14 g; 4%, 198±25 g and
0%, 143±5 g. Rats fed a 0% or a 4% protein diet
consumed significantly less food than did animals
fed a 8%, 12% or 20% protein diets (table 1).
However, the animals that received the 0% and
4% protein diets ate significantly more food per
gram of body weight than did animals that received
8%, 12% and 20% protein diets (table 1). Thus
the 0% and 4% protein diets induced protein
deficiency, but not energy deficiency, since these
animals consumed equal or greater number of
calories that did rats on 8%, 12% and 20% protein
diets.
Relative distribution of lymphocytes in
lymphoid organs
The cellular distribution of CD4+ T cells, CD8+ T
cells and B cells in the spleen, mesenteric lymph
nodes and peripheral blood of male rats fed various
diets is shown in table 2. The percentage of CD4+
T cells in these tissues did not differ among rats
fed 4, 8, 12, or 20% protein diets; however a trend
to increase was seen in the spleen of rats fed 0%
407
Biomédica 2004;24:403-12  PROTEIN MALNUTRITION AND GH RECEPTOR ON LYMPHOID CELLS
Table 1. Total food intake and food intake per body weight in rats fed the different protein diets.
Protein
in diet (%) 0 4 8 12 20
Total food* 10.2 ± 0.27† 14.1 ± 1.2§ 17.2 ± 0.63? 17.5 ± 0.21? 18.5 ± 0.07?
Food/BW** 1.75 ± 0.07† 1.62 ± 0.07† 1.39 ± 0.01§ 1.33 ± 0.07§ 1.29 ± 0.07§
All values expressed as mean ± s.e.m. from n=6 rats in each group. BW, body weight.
* Food consumption [food (g) per animal per day]
** Food consumption [food (g)/final body weight (g) per animal]
Superscripts represent significant differences between treatment groups. Means not sharing the same superscripts are
different at P‹0.05.
protein diet. Conversely, the percentage of CD4+
T cells was significantly diminished in lymph
nodes in rats fed 0% protein diet. The percentage
of CD8+ T cells in the spleen and peripheral blood
was significantly (P<0.05) lower in rats fed 0%
protein diet compared to animals fed with 12 or
20% protein diets. In contrast, the percentage of
B cells tended to increase in spleen, mesenteric
lymph nodes and peripheral blood as the amount
of dietary protein decreased. In rats fed 0 and 4%
protein diets, the percentage of B cells in lymph
nodes and peripheral blood was significantly higher
than in animals fed 8, 12 and 20% protein diets
(P<0.05). The percentage of splenic B cells was
significantly lower in rats fed 20% protein diet than
in animals fed 4 or 0% protein diets (P<0.05).
Binding characteristics of Fluos-rrGH to rat
splenocytes demonstrated by flow
cytofluorometric analysis
Fluos-rrGH was able to bind specifically to GHR
in rat splenocytes and the IM-9 cell line. The total
binding of Fluos-rrGH saturation occurred with 1
µg of rrGH and 2 h of incubation at 4°C for both
cell types (data not shown). Competition analysis
with unlabeled rrGH showed that binding to
splenocytes and IM-9 cells was specific. Figure 1
shows that a 75% inhibition of binding was
obtained with 100 µg of unlabeled hormone on IM-
9 cells; similar results were obtained in
splenocytes. No inhibition in both cases was
observed using Fluos-BSA.
Relative distribution of growth hormone
receptors on lymphocytes from lymphoid
tissues
Table 3 lists the relative distribution of GHR on the
corresponding tissues analyzed. Among the
tissues analyzed, splenic lymphocytes were the
most responsive to changes in the dietary protein
content (figure 2). Rats fed 0 and 4% protein diets
had a 4 and 2-fold increase respectively in the
percentage of GHR+ B cells, as compared to rats
fed diets containing either 12 or 20% protein.
Interestingly, dietary protein restriction did not
affect significantly the expression of GHR on both
Table 2. Relative lymphocyte distribution in rat lymphoid tissues according to the level of dietary protein.
Protein in diet (%)  0  4 8 12  20
Tissue  Subpopulation (%)
Spleen CD4 38 ± 2.7 33.3 ± 4.1 28.6 ± 3.1 31.3 ± 2.7 32   ± 3.2
CD8 19.7 ± 2.1† 26.3 ± 5.6†§ 21.3 ± 2.7† 21  ±  2.2† 29.7 ± 3.1§
CD45RA 28.3 ± 2.7† 25 ±  4.8† 31.3 ± 3.3† 26.7 ± 4.4† 22   ± 2.4§
Lymph CD4 55.3 ± 2.7† 59.7 ± 1.4§ 62.9 ± 0.4§ 61.3 ± 0.5§ 62   ± 1.4§
nodes CD8 26.7 ± 1.5 24.7 ± 0.6 24.2 ± 1.2 24.8 ± 0.8 28.3 ± 1.7
CD45RA 16.2 ± 1.6† 12.7 ± 1.7† 11.7 ± 2.1§ 10.9 ± 1.8§ 8.2 ± 1.4§
PBL CD4 42.7 ± 2.3 38.7 ± 1.9 47.9 ± 2.7 51.9 ± 1.1 47.4 ± 3.6
CD8 23.6 ± 1.4† 21.2 ± 0.2† 21  ± 0.9† 27.3 ± 1.2§ 29   ± 1.8§
CD45RA 26.5 ± 3.2† 28.1 ± 2.4† 22  ± 1.5§ 18.8 ± 0.8§ 18   ± 4.3§
The mean ± s.e.m. (n=6) is represented for each group. Superscripts represent significant differences between treatment
groups. Means not sharing the same superscripts are different at P‹0.05. Means without superscripts are not different.
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Figure 1. Specificity of Fluos-rrGH binding to GHR. The
total binding of Fluos-rrGH to the IM-9 lymphocyte cell line
(black square) corresponded to 90%. A 100-fold excess
of unlabeled rrGH inhibited the binding of Fluos-rrGH by
75% to IM-9 cells. The total binding of Fluos-rrGH to
splenocytes (open square) corresponded to 23%. A 100-
fold excess of unlabeled rrGH inhibited the binding of Fluos-
rrGH by 70%.
mesenteric lymph nodes and peripheral blood
lymphocytes.
Serum growth hormone levels
Serum GH levels were markedly decreased in
response to decreasing dietary protein content as
shown in figure 3A. In the groups that received
Figure 2. Cytofluorometric detection of GHR on CD45RA splenocytes. Animals were fed diets consisting of either 0%
(panel A), 4% (panel B), 8% (panel C), 12% (panel D) or 20% (panel E) protein for 14 days, as indicated. Splenocytes
were obtained as described and stained with fluos-rGH and anti-CD45RA-PE-conjugated antibody. The percentage of
immunelabeled B cells for the GHR was determined by FACS. The percentage of GHR- (upper left) and GHR-bearing cells
(upper right) is indicated in each panel. Panel F shows a representative negative control, fluos-BSA and mouse IgG1
isotype-PE antibody. One representative profile of n=6 rats in each group is presented.
20% and 12% protein diets, serum GH levels were
similar, whereas in the groups that received 8%,
4% and 0% protein diets were significantly lower
(P<0.05) compared to animals fed 20% protein diet.
Serum prolactin levels
Serum prolactin levels increased in response to
decreasing the dietary protein content as shown
in figure 3B. Prolactin levels on day 0 were 12.5 ±
3 ng/ml. On day 14, serum levels of animals fed
with 20% or 12% protein diet  remained unchanged,
whereas in rats fed 8% and 4% protein diet,
prolactin levels showed an increase, 26.3 ± 3.8
ng/ml  and 18.6  ± 3.2 ng/ml respectively. Serum
levels in rats fed 0% protein diet were similar to
the control.
Serum insulin levels
Serum insulin levels progressively decreased in
response to decreasing the dietary protein content,
as shown in figure 3C. In rats fed 0 and 4% protein
diets, serum insulin levels were significantly lower
(P<0.05) than those observed in rats fed 8, 12 or
20% protein diets.
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Table 3. Relative distribution of growth hormone receptors (GHR) on lymphocyte subpopulations in rat lymphoid tissues
according to the level of dietary protein.
Protein in diet (%) 0 4 8  12   20
Tissue    Subpopulation (%)
Spleen CD4 17.4 ± 3.1† 9.2 ± 2.9§ 13.9 ± 2.5† 6.1 ± 1.3§ 8  ± 0.7§
CD8 22.2 ± 1.3† 10.4 ± 3.0§ 8.6  ± 1.6§  5.9 ± 3.1§ 8.3 ± 2.2§
CD45RA 51.9 ± 4.4† 27.7±  7.6§ 16.9± 2.2§?| 12.6± 3.2? 12.2 ± 3.7?
Lymph CD4 3.9 ± 0.6† 2.3 ± 0.4† 1.8 ± 1.1† 4.9 ± 2.3† 3.1  ± 1.2§
nodes CD8 4.2 ± 0.5 3.9 ± 0.6 3.8 ± 1.1 4.2 ± 0.2 3.1 ± 1
CD45RA 13.2 ± 1.3 12 ± 2.7 10 ± 1.6 12.8 ± 1.4 13.9 ± 5.4
PBL CD4 1  ± 0.2 0.7 ± 0.1 0.5 ± 0.1 0.3 ± 0.1 0.5 ± 0.2
CD8 1.1 ± 0.1 1  ±  0.2 0.9 ± 0.1 0.9 ± 0.2 0.5 ± 0.2
CD45RA 1  ± 0.2 1.7 ± 0.4 0.9 ± 0.1 1   ± 0.1 1.5 ± 0.4
All values expressed as mean ± s.e.m. from n=6 rats in each group. Superscripts represent significant differences
between treatments groups; means not sharing the same superscripts are different at P‹0.05. Means without superscripts
are not different.
Figure 3. Effect of dietary protein
restriction on serum GH levels (A),
prolactin (B) and insulin (C) on day
14. Rats were fed diets consisting
of either 0, 4, 8, 12 or 20% protein
for 14 days, as indicated. Data
points indicate individual serum GH
levels in ng/ml from n=6 rats in each
group. Prolactin and insulin data are
expressed as average serum
levels ± s.e.m., in ng/ml, from n=6
rats in each group. a P<0.05 vs.
control fed 12% or 20% protein
diets.
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Serum IGF-I levels
Table 4 lists the changes in serum IGF-I
concentrations over the 14-days period. On day 0
circulating levels were similar, but by day 14,
similar to serum GH levels, circulating IGF-I levels
progressively decreased in response to decreasing
the dietary protein content. On day 14 the levels
were significantly lower in the group fed 8% protein
diet, and further reduced in the groups that
received 4% and 0% protein diets compared to
animals fed 20% protein diet. Interestingly, in the
animals that received 12% protein diet the serum
levels remained unchanged over the experimental
period, whereas in the group that received 20%
protein diet the levels increased significantly
(P<0.05) compared to the serum concentrations
on day 0.
Serum IGFBP-3 and IGFBP-1 levels
The effect of dietary protein restriction on the serum
IGFBPs molecular distribution is shown in figure
4. It is evident that serum IGFBP-3 levels (40-45
kd) progressively decreased as the amount of
protein intake was decreased. In rats fed 0 and
4% protein diets, there was a significant reduction
(P<0.01) in serum IGFBP-3 levels, 87 and 59%
respectively compared to animals fed a 20%
protein diet. In rats fed 8 and 12% protein diets a
non-significant reduction of 25% was observed. The
western ligand blots show that IGFBP-1 levels (25-
28 kd) did not change significantly among the
animals fed the various protein diets.
Discussion
The effects of hormones on the proliferation and
differentiation of immune cells has been widely
appreciated and the importance of the GH/IGF-I
axis in immune responsiveness is also under
study. A recent hypothesis has suggested that
the immunomodulatory effects of GH and IGF-I may
be explained in terms of their anabolic and
somatogenic actions (1, 2).
The purpose of this study was to determine the
relative distribution of growth hormone receptors
on lymphocytes from some lymphoid tissues as
well as some elements associated to the GH/IGF-
I axis in rats under protein malnutrition. This
investigation together with recent repor ts
represents the original studies demonstrating up-
regulation of the GHR population in lymphoid
tissues after protein deprivation (9,10). Growth
hormone receptor expression was assayed by
flow cytofluorometric analysis using Fluos-rrGH
to characterize the distribution of GHR together
with specific PE-labeled mAbs defining CD4+ and
CD8+ T cells and B lymphocytes from lymphoid
cell populations. The binding of Fluos-rrGH to its
receptor in splenocytes and IM-9 cells showed
similar characteristics; it was saturable and
specific. This finding makes this ligand a useful
tool in flow cytometry studies of paracrine/
autocrine actions of the GH.
It has been shown that GHR is expressed in
murine hematopoietic tissues, including primary
and secondary lymphoid organs (12). We found
that the pattern of expression is different among
the different lymphoid tissues studied, as well as,
among the various cell subsets. It is well known
that fasting or protein calorie malnutrition
decreases the GHR expression in the liver causing
a resistance to the growth hormone action; less
severe malnutrition such as a decreased protein
intake, does not affect the GH binding but some
post-receptors defects have been described (11,
13). In this study of protein deprivation at various
levels, an increase in the GHR binding has been
observed. Among the secondary lymphoid organs
Table 4. Total serum IGF-I concentrations (ng/ml).
Protein in diet  (%) 0 4 8 12 20
Day        0 478 ± 114 415 ± 92 449 ± 54 482 ± 80 493 ± 74
              14 19 ± 15† 72  ± 39§ 281 ± 147? 472 ± 68± 870 ± 27¶
The mean ± s.e.m (n=6) is represented for serum collected on given days. Superscripts represent significant differences
between treatment groups; means not sharing the same superscripts are different at P‹0.05. Means without superscripts
are not different.
411
Biomédica 2004;24:403-12  PROTEIN MALNUTRITION AND GH RECEPTOR ON LYMPHOID CELLS
Figure 4. Effect of dietary protein restriction on serum IGFBP-3 and IGFBP-1 levels. Rats were fed diets consisting of
either 0, 4, 8, 12 or 20% protein for 14 days, as indicated. Data are expressed as average IGFBP-3 levels (A) or IGFBP-
1 levels (B) as fold increase over control fed 20% protein diet ± s.e.m., in ng/ml from n=6 rats in each group. A representative
ligand blot asssay of serum from rats fed the various diets (2 lanes per group) is shown. Proteins were separated on 4-
20% SDS-PAGE and IGFBPs were detected by incubation with 125 I-IGF-I. a P<0.01 vs control fed 12% or 20% protein diets.
analysed, the spleen was the most responsive to
this phenomenon with the B lymphocytes
expressing more GHR followed by CD4+ T cells.
According to our results, as the protein intake
decreases, the percentage of splenic CD4+ T cells
and B lymphocytes increases and more cells (2-4
fold) become responsive to GH. Although the
percentage of CD8+ T cells decreased, up-
regulation of the GHR was seen in the three splenic
cell subsets in response to the nutritional insult.
These results were also shown in mice under
protein malnutrition (10) and it was further
demonstrated that an increase in the mature
CD4+CD8- thymocytes might explain the   increase
in the CD4+ T lymphocytes (14). In contrast,
despite the increased percentage of B cells
induced by the protein restriction in mesenteric
lymph nodes and peripheral blood, only 10-13%
in the lymph nodes and 2-4% of the lymphocytes
in circulation bind the GH and no significant
changes were induced by the protein deprivation.
It is more likely that most cells bearing the GHR
remain in the tissue due to the anabolic action in
order to preserve the homeostasis. The GHR
expression in the thymus is much reduced under
normal protein intake compared to the other tissues
analyzed (<1%, data not shown). Our results are
coherent with those of Gagnerault et al. (12), who
detected higher levels of GHR expression in B
than in T lymphocytes from mice hematopoietic
tissues. According to the current information and
these results, rat and mouse are very similar in
the pattern of GHR expression with higher positive
cells in spleen than in mesenteric lymph nodes,
peripheral blood lymphocytes and thymus.
The autocrine/paracrine mode of action of the GH/
IGF-I axis in the immune system is currently under
study, but the regulatory effect of the dietary
protein has not been clarified. In order to have a
systemic approach to some elements of this axis
serum IGF-I, GH, prolactin, insulin and IGFBP-1
and -3 were determined. Nutritional status is known
to regulate these elements (8); as expected, serum
IGF-I, GH, insulin and IGFBP-3 levels were
progressively reduced in response to decreasing
the protein intake.
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Prolactin is a lactogenic hormone associated with
the response to stress (15). In this study, we found
that a low protein intake regulates the serum
concentration of prolactin, with a marked
increment after 5 days of protein restriction. It has
been proposed that prolactin secretion is increased
in order to partially counteract the negative
suppressive effects on the immune system of
glucocorticoid response to stress (16).
In conclusion, among the lymphoid tissues
studied, GH receptors in spleen-derived
lymphocytes showed to be more responsive to
the stress caused by a low or deficient protein
intake with a 2-4 fold increase and a highest
expression in B lymphocytes, followed by CD4+
T cells. These results support the hypothesis of
an immunomodulatory role of the GH/IGF-I axis
in preserving the homeostasis of the immune
tissues.
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